Alnylam Pharmaceuticals (ALNY) Posts Quarterly Earnings Results, Misses Estimates By $0.40 EPS

Alnylam Pharmaceuticals (ALNY) Posts Quarterly Earnings Results, Misses Estimates By $0.40 EPS


Alnylam Pharmaceuticals announced its quarterly earnings data on Wednesday. The biopharmaceutical company reported earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of by , MarketWatch Earnings reports.



from Biotech News